Oramed Pharmaceuticals (ORMP) Financial Statements & Analysis

Oramed Pharmaceuticals Income Statement Analysis

Values in millions USD

Income Statement Balance Sheet Cash Flow Ratios

Scale:

Scroll to see more

Oramed Pharmaceuticals Inc. income statement - Annual data in millions USD
Breakdown	FY 2025	FY 2024	FY 2023	FY 2023	FY 2022	FY 2021	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2012
Period ending	Dec 2025	Dec 2024	Dec 2023	Sep 2023	Dec 2022	Dec 2021	Aug 2021	Aug 2020	Aug 2019	Aug 2018	Aug 2017	Aug 2012
Revenue & Gross Profit
Revenue	2.00	0.00	1.34	1.34	2.70	2.71	2.70	2.71	2.70	2.45	2.46	-
Cost of Revenue	1.99	0.00	-	0.00	0.00	-	0.00	0.00	0.09	0.09	0.19	-
Gross Profit	0.01	0.00	1.34	1.34	2.70	0.90	2.70	2.71	2.61	2.36	2.27	-
Operating Expenses
Research & Development	6.38	6.32	8.97	8.97	27.64	27.11	20.99	10.24	13.52	11.98	10.28	-1.68
Selling, General & Administrative	8.72	6.46	8.14	8.14	15.66	12.58	5.94	4.23	3.72	4.08	2.76	-1.20
Operating Expenses	15.10	12.78	17.11	17.11	43.30	-13.23	26.93	14.47	17.24	16.06	13.04	-2.88
Operating Income	-15.09	-12.78	-15.77	-15.77	-40.60	12.33	-24.22	-11.76	-14.63	-13.53	-10.77	2.88
Other Income/Expense
Interest Income	89.45	4.98	8.17	8.03	3.57	0.35	0.35	0.69	1.06	0.90	0.79	-13.13
Interest Expense	0.00	0.85	2.04	3.58	0.00	-	0.00	0.00	0.00	0.01	0.01	-
Other Income/Expense	90.41	-7.24	16.27	20.86	-0.63	0.07	0.89	0.25	-0.45	-0.03	-0.01	-13.11
Income
Income Before Tax	75.32	-15.92	5.09	5.09	-37.66	-36.77	-22.99	-11.51	-14.06	-12.73	-10.08	3.25
Income Tax Expense	11.31	3.18	-	0.00	0.10	-	0.00	0.00	0.30	-0.80	0.40	-0.09
Net Income	64.05	-19.06	5.53	5.53	-36.56	11.67	-22.24	-11.51	-14.36	-12.73	-10.48	3.34
Net Income - Continuous Operations	64.05	-19.10	5.09	5.53	-37.76	-	-22.99	-11.51	-14.36	-12.73	-10.48	-
Net Income - Discontinued Operations	-	-	-	-	-	-	-	-	-	-	-	-
EBITDA	-14.97	-14.87	7.32	7.32	-37.61	-36.92	-24.15	-11.75	-14.17	-13.49	-10.76	2.90
EBIT	-15.09	-15.07	7.13	-	-37.66	-36.98	-24.22	-	-	-	-	2.88
Depreciation & Amortization	0.12	0.19	0.20	0.20	0.06	0.08	0.08	0.01	0.01	0.01	0.01	-
Earnings Per Share
Basic EPS	2.00	-	-	-	-1.00	-1.00	-1.00	-1.00	-1.00	-1.00	-1.00	-1.00
Diluted EPS	2.00	-	-	-	-1.00	-	-1.00	-1.00	-1.00	-1.00	-1.00	-1.00
Basic Shares Outstanding	41.40	40.85	40.32	40.32	39.00	37.11	28.47	20.53	17.45	14.88	13.31	5.88
Diluted Shares Outstanding	42.42	40.85	40.57	40.57	39.00	37.11	28.47	20.53	17.45	14.88	13.31	5.88

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About Oramed Pharmaceuticals Financial Statements

What was Oramed Pharmaceuticals's revenue in fiscal 2025?

Oramed Pharmaceuticals reported revenue of $2.00M in fiscal 2025 (fiscal year ended Dec 31, 2025).

Is Oramed Pharmaceuticals profitable?

Yes. Oramed Pharmaceuticals earned net income of $64.05M in fiscal 2025, a net margin of 3202.5%. In fiscal 2024 it lost $19.06M.

What is Oramed Pharmaceuticals's operating margin?

Oramed Pharmaceuticals's operating income was −$15.09M on revenue of $2.00M in fiscal 2025, an operating margin of -754.4%.

What is net profit margin?

Net profit margin is net income divided by revenue. It shows how much of each dollar of sales a company keeps as profit after all costs, interest and taxes. Full definition